Press Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant
Sarclisa is the first anti-CD38 treatment approved in China for patients with…
Datar Cancer Genetics to Provide Groundbreaking Video-Enhanced Results of In-Vitro Chemotherapy Effectiveness Tests for Cancer Patients
NEW DELHI and LONDON and MUNICH, Jan. 28, 2025 /PRNewswire/ -- Datar…
Dentzz Dental Reports Serving Over 100,000 Patients Worldwide, Highlighting Dental Tourism Trends
Photo credit: Dentzz Dental MUMBAI, India, Jan. 24, 2025 (GLOBE NEWSWIRE) --…
Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH
January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast…
Dentzz Dental Reports Serving Over 100,000 Patients Worldwide, Highlighting Dental Tourism Trends
Photo credit: Dentzz Dental MUMBAI, India, Jan. 24, 2025 (GLOBE NEWSWIRE) --…
Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH
January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast…
Dentzz Dental Reports Serving Over 100,000 Patients Worldwide, Highlighting Dental Tourism Trends
Photo credit: Dentzz Dental MUMBAI, India, Jan. 24, 2025 (GLOBE NEWSWIRE) --…
Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH
January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast…
Santhera Receives Positive Recommendation from Scottish Medicines Consortium for the Use of AGAMREE (Vamorolone) in Duchenne Muscular Dystrophy Patients in NHS Scotland
Santhera Receives Positive Recommendation from Scottish Medicines Consortium for the Use of…
HUTCHMED Announces NMPA Full Approval for ORPATHYS(savolitinib) in China for Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC
January 13, 2025 23:00 ET | Source: HUTCHMED (China) Limited — Indication…